• Regulatory Affairs
• Research & Development
• Production
• Clinical Trials
• Medical Science
• Pharmaceutical Economics
• Trainee Positions
• Training
• Sales / Field Service
• Pharmaceutical Consultant / Medical Representative(m/f)
• Pharmacist (m/f) in Sales

Pharmaceutical Consultant / Medical Representative (m/f)

Basically, pharmaceutical consultants or representatives are the link between the drug manufacturers and their direct customers (medical doctors and pharmacists). In individual cases, they may also be in direct contact with the users (patients), for instance, if they support HIV self-help groups.

The German Drug Law (AMG) provides an exact definition of this professional group in paragraphs 75 und 76a:

§ 75 Expert Knowledge

(1) Pharmaceutical companies may only commission persons with expert knowledge, as specified in clause 2, to visit members of the healing professions on a full-time basis to provide them specialist information on drugs in the sense of § 2 clause 1 or clause 2 no. 1 (pharmaceutical consultants). Clause 1 also applies for information provided by telephone. Other persons than those specified in clause 1 must not work as pharmaceutical consultants.

(2) The following persons have this expert knowledge:

1. Pharmacistis or persons with a certificate that proves that they have completed university education in pharmacy, chemistry, biology, human or veterinary medicine;

2. Pharmaceutical assistants and persons that have completed training as technical assistant in pharmacy, chemistry, biology, human or veterinary medicine;

3. Persons that have completed further professional training as certified pharmaceutical expert.

(3) The respective authority may acknowledge a passed exam or completed education that is equal to one of the educations and trainings of persons listed in clause 2 as sufficient.

§ 76 Obligations

(1) If the pharmaceutical consultant provides expert information to members of the healing professions on individual drugs, he/she must submit these information sheets for experts according to §11a AMG. He/she must write down information provided by members of the healing profession on side effects and contraindications and other risks related to drugs and provide this information to the customer in written form.

(2) To the extent to which the pharmaceutical consultant has been commissioned by the pharmaceutical entrepreneur to hand out samples of finished medicinal products to persons authorized according to §47 para. 3, he/she must document the recipient of such samples, the kind, scope and time of transfer and submit this documentation to the respective authority upon request.